SUBSCRIBE
SUBSCRIBE
News   FDA

St. Jude Medical Announces FDA and European CE Mark Approval of the QuickFlex Family of Leads

January 22, 2008 | 
1 min read
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) and European CE Mark approval of the QuickFlex™ family of left-heart leads to treat heart failure patients.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Contemporary art collage. Giang hand kicking office worker symbolizing dismissal. Unsuccessful employee. Job reduction. Concept of business, career, failure, success, troubles
Rare diseases
Ultragenyx Takes Second Hit as FDA Rejects Gene Therapy for Sanfilippo Syndrome
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Regulatory
FDA Mulls Speedier Reviews to Companies Willing To Lower Drug Costs
July 14, 2025
 · 
1 min read
 · 
Tristan Manalac
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Complete response letters
Capricor Plunges on FDA Rejection of DMD Cell Therapy
July 11, 2025
 · 
3 min read
 · 
Tristan Manalac
Cambridge, USA - 16 August 2024. View of Moderna office entrance with logo sign, Biotechnology industry
COVID-19
Moderna Wins Full Approval for COVID-19 Shot for Higher-Risk Kids
July 11, 2025
 · 
2 min read
 · 
Tristan Manalac